col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

1143 Results       Page 1

Elsevier: The Lancet
  original article Date Title Authors   All Authors
1 [GO] 2024―Jul―11 Long COVID politics and activism Emily Mendenhall
2 [GO] 2024―Jun―18 Political courage needed to prevent the next pandemic Helen Clark, Mauricio Cárdenas, Mark Dybul, Michel Kazatchkine, Joanne Liu, Henry E Mark, et al. (+9)
3 [GO] 2024―Jun―13 Improving future UK pandemic management structure Ian Kunkler
4 [GO] 2024―May―16 One Health pandemic preparedness: the role of companion animals in disease transmission Adrian J Marcato, Niamh Meagher, Violeta Spirkoska, Alicia Arnott, Jodie McVernon, David J Price, Juan-Pablo Villanueva-Cabezas
5 [GO] 2024―May―09 Organisations vie for control over pandemic financing Ann Danaiya Usher
6 [GO] 2024―May―07 The long COVID evidence gap in England Anika Knuppel, Andy Boyd, John Macleod, Nishi Chaturvedi, Dylan M Williams
7 [GO] 2024―Apr―08 Anticipating a MERS-like coronavirus as a potential pandemic threat Alimuddin Zumla, Malik Peiris, Ziad A Memish, Stanley Perlman
8 [GO] 2024―Apr―04 High-dose corticosteroid therapy in COVID-19: the RECOVERY trial Nin-Chieh Hsu, Yasuharu Tokuda
9 [GO] 2024―Apr―04 High-dose corticosteroid therapy in COVID-19: the RECOVERY trial Teluguakula Narasaraju, Yazhini Ravi, Colleen B Jonsson, Vincent T K Chow
10 [GO] 2024―Apr―04 High-dose corticosteroid therapy in COVID-19: the RECOVERY trial Zia Hashim, Alok Nath, Naresh Kumar Tripathy
11 [GO] 2024―Apr―04 High-dose corticosteroid therapy in COVID-19: the RECOVERY trial Sangeeta Bhusal, Sudeep Adhikari
12 [GO] 2024―Apr―04 High-dose corticosteroid therapy in COVID-19: the RECOVERY trial Natalie McEvoy, Jessica Lowry, Aidan O'Dowd, Gerard F Curley, Fidelma Fitzpatrick
13 [GO] 2024―Apr―04 High-dose corticosteroid therapy in COVID-19: the RECOVERY trial - Authors' reply Leon Peto, Buddha Basnyat, Peter Horby
14 [GO] 2024―Mar―28 UN rights expert: do not neglect prisons in pandemic plans John Zarocostas
15 [GO] 2024―Mar―22 Governance provisions in the WHO Pandemic Agreement draft Nina Schwalbe, Elliot Hannon, Lynda Gilby, Susanna Lehtimaki
16 [GO] 2024―Mar―22 A legal mapping of 48 WHO member states' inclusion of public health emergency of international concern, pandemic, and health emergency terminology within national emergency legislation in responding to health emergencies Clare Wenham, Liam Stout
17 [GO] 2024―Mar―22 The importance of reporting accurate estimates of long COVID prevalence Joshua Szanyi, Samantha Howe, Tony Blakely
18 [GO] 2024―Mar―19 Improving coherence of global research funding: Pandemic PACT Alice Norton, Louise Sigfrid, Emilia Antonio, Adrian Bucher, Duduzile Ndwandwe
19 [GO] 2024―Mar―11 Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign Marianne Shawe-Taylor, David Greenwood, Agnieszka Hobbs, Giulia Dowgier, Rebecca Penn, Theo Sanderson, et al. (+14)
20 [GO] 2024―Mar―11 Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 Austin E Schumacher, Hmwe Hmwe Kyu, Amirali Aali, Cristiana Abbafati, Jaffar Abbas, Rouzbeh Abbasgholizadeh, et al. (+1830)
21 [GO] 2024―Mar―07 mRNA-based therapeutics: looking beyond COVID-19 vaccines Hamideh Parhiz, Elena N Atochina-Vasserman, Drew Weissman
22 [GO] 2024―Feb―29 The Pandemic Treaty: shameful and unjust The Lancet
23 [GO] 2024―Feb―20 Candour, care, and COVID-19 Rageshri Dhairyawan
24 [GO] 2024―Feb―08 Draft of WHO Pandemic Agreement plays down primary prevention Thomas C Mettenleiter, Andrea S Winkler, Robyn Alders, John H Amuasi, Sania Ashraf, Daniel Becker, et al. (+24)
25 [GO] 2024―Jan―21 Undervaccination and severe COVID-19 outcomes: meta-analysis of national cohort studies in England, Northern Ireland, Scotland, and Wales Steven Kerr, Stuart Bedston, Genevieve Cezard, Alexia Sampri, Siobhan Murphy, Declan T Bradley, et al. (+21)
26 [GO] 2024―Jan―21 The Tokyo 2020 and Beijing 2022 Olympic Games held during the COVID-19 pandemic: planning, outcomes, and lessons learnt Brian McCloskey, Tomoya Saito, Satoshi Shimada, Chiaki Ikenoue, Tina Endericks, Lucia Mullen, et al. (+6)
27 [GO] 2024―Jan―15 Access to COVID-19 vaccination and COVID-19-related hospital admissions and mortality Martin C Gulliford, Claire J Steves
28 [GO] 2024―Jan―11 Interpreting COVID-19 data from China: a call for caution Zhi Qu
29 [GO] 2024―Jan―11 Interpreting COVID-19 data from China: a call for caution - Authors' reply Liang Wang, Quanyi Wang, George F Gao
30 [GO] 2024―Jan―11 Effects of the COVID-19 pandemic on NHS England waiting times for elective hospital care: a modelling study Syed Ahmar Shah, Chris Robertson, Aziz Sheikh
31 [GO] 2023―Dec―20 How modelling can better support public health policy making: the Lancet Commission on Strengthening the Use of Epidemiological Modelling of Emerging and Pandemic Infectious Diseases
32 [GO] 2023―Dec―15 Death and end of life in France after COVID-19 Philippe Charlier
33 [GO] 2023―Dec―15 Offline: Boris Johnson and COVID-19-more light than heat Richard Horton
34 [GO] 2023―Nov―24 Untangling the association between COVID-19 health literacy, trust in the pandemic response, and mental distress, during the COVID-19 pandemic in Ireland: a repeated cross-sectional study Julie Arnott, Maria Isabela Troya, Mary Joyce, Ali Khashan, Paul Corcoran, Zubair Kabir, et al. (+2)
35 [GO] 2023―Nov―24 Impact of long COVID-19 on work: a co-produced survey Nida Zia�n, Marija Pantelic, Margaret E O’Hara, Claire Hastie, Nisreen A Alwan
36 [GO] 2023―Nov―24 The role of the multiple Index of deprivation in predicting mental health outcomes after the COVID-19 pandemic in adolescents: a cross-sectional study Serendi Gulsen Hazir, Cían Ryan, Alison Moore, Charlie Lewis, Judith Lunn
37 [GO] 2023―Nov―24 Differences in the impact of the COVID-19 pandemic in the long-term trajectories of life satisfaction by sex in the UK: a prospective cohort study Darío Moreno-Agostino, Jayati Das-Munshi, George B Ploubidis
38 [GO] 2023―Nov―24 Changes in food and drink purchasing behaviour in England during the first 3 months of the COVID-19 pandemic: an interrupted time-series analysis Alexandra Kalbus, Laura Cornelsen, Andrea Ballatore, Steven Cummins
39 [GO] 2023―Nov―24 The Sussex COVID-19 Modelling Cell: the methods and successes of a collaboration between public health teams in local authorities, NHS hospital trusts, NHS commissioners, and universities James Van Yperen, Eduard Campillo-Funollet, Anjum Memon, Phil Allman, Jacqueline Clay, Matt Dorey, et al. (+3)
40 [GO] 2023―Nov―24 Mitigation of respiratory syncytial virus epidemics by RSVpreF vaccines after the COVID-19 pandemic in the UK: a modelling study Zhanwei Du, Lin Wang, Yuan Bai, Yao Pei, Peng Wu, Benjamin J Cowling
41 [GO] 2023―Nov―24 Impact of the COVID-19 pandemic on delayed care of cardiovascular diseases in Europe: a systematic review Yasmine Khan, Nick Verhaeghe, Brecht Devleesschauwer, Lisa Cavillot, Sylvie Gadeyne, Nele S Pauwels, et al. (+2)
42 [GO] 2023―Nov―24 Effect of trade unions on the mental health of UK workers before and during the COVID-19 pandemic: a longitudinal analysis using Understanding Society data Theocharis Kromydas, Evangelia Demou, Alastair H Leyland, Srinivasa Vittal Katikireddi, Jacques Wels
43 [GO] 2023―Nov―24 Exploring the experiences of junior doctors who were shielding during the COVID-19 pandemic: a qualitative study of semi-structured interviews Amy Martin, Susan Jamieson
44 [GO] 2023―Nov―09 Listening to the experiences of pandemic physicians Roopa Farooki
45 [GO] 2023―Nov―01 SARS-CoV-2 neutralising antibodies after a second BA.5 bivalent booster Qian Wang, Anthony Bowen, Jerren Ho, Richard M Zhang, Riccardo Valdez, Emily Stoneman, et al. (+3)
46 [GO] 2023―Oct―30 A crisis of trust in pandemic prevention, preparedness, and response Kolinda Grabar-Kitarović, Joy Phumaphi
47 [GO] 2023―Oct―12 Scientific advisory councils in the COVID-19 response Jean-François Delfraissy, Mary Horgan, Kåre Mølbak, Fernando Soria Simón, Tanja Stadler, Jaap van Dissel, et al. (+52)
48 [GO] 2023―Oct―11 The Lancet-PPATS Commission on Prevention of Viral Spillover: reducing the risk of pandemics through primary prevention Neil M Vora, Latiffah Hassan, Raina K Plowright, Richard Horton, Sonila Cook, Nigel Sizer, Aaron Bernstein
49 [GO] 2023―Oct―03 A gender-responsive Pandemic Accord is needed for a healthier, equitable future Shirin Heidari, Els Torreele, Ahmet Metin Gülmezoglu, Sharifah Sekalala, Naomi Burke-Shyne, Gabrielle Landry Chappuis
50 [GO] 2023―Sep―28 Striving to afford free health care in Greece during COVID-19 Christos Tsagkaris, Andreas S Papazoglou, Dimitrios V Moysidis, Stavros P Papadakos, Marios Papadakis
51 [GO] 2023―Sep―28 Cautionary notes on the COVID-19 re-infection study Zhi Qu
52 [GO] 2023―Sep―28 Community COVID-19 response in WHO's European region Leonardo Palumbo, Camila A Picchio, Catherine Smallwood, Cristiana Salvi, Gerald Rockenschaub
53 [GO] 2023―Sep―28 Arcturus (XBB.1.16) COVID-19 subvariant emergence in Indonesia Tungki Pratama Umar
54 [GO] 2023―Sep―28 Overcoming COVID-19 vaccine hesitancy hurdles Chengliang Yang, Linda Lapp, Scott J Tebbutt
55 [GO] 2023―Sep―28 COVID toes, newborn blue toes, and prepartum SARS-CoV-2 infection Ya Bin Zhou, Zi Gang Xu
56 [GO] 2023―Sep―28 COVID toes, newborn blue toes, and prepartum SARS-CoV-2 infection - Authors' reply Christoph Hochmayr, Ursula Kiechl-Kohlendorfer, Elke Griesmaier
57 [GO] 2023―Sep―28 Natural SARS-CoV-2 infection-induced immune protection against re-infection Claude Matuchansky
58 [GO] 2023―Sep―25 WHO pandemic accord: full adherence to the principle of sovereignty Ahmed Soliman, Kazuho Taguchi, Precious Matsoso, Roland Alexander Driece, Tovar da Silva Nunes, Viroj Tangcharoensathien
59 [GO] 2023―Sep―21 COVID-19 and Chinese nurses' mental health Hong Zhang
60 [GO] 2023―Sep―21 Bolsonaro's Ministry of Health's response to COVID-19 and other health challenges Raphael C M Parente, Marcelo Queiroga
61 [GO] 2023―Sep―21 Bolsonaro's Ministry of Health's response to COVID-19 and other health challenges - Authors' reply Adriano Massuda, Rafael Dall'Alba, Arthur Chioro, José Gomes Temporão, Márcia C Castro
62 [GO] 2023―Sep―15 What happened to the mpox pandemic? Tony Kirby
63 [GO] 2023―Sep―04 Increasing compliance with international pandemic law: international relations and new global health agreements Matthew M Kavanagh, Clare Wenham, Elize Massard da Fonseca, Lawrence R Helfer, Elvin Nyukuri, Allan Maleche, et al. (+3)
64 [GO] 2023―Aug―28 Long COVID in low-income and middle-income countries: the hidden public health crisis Waasila Jassat, Luis Felipe Reyes, Daniel Munblit, Janice Caoili, Fernando Bozza, Madiha Hashmi, et al. (+4)
65 [GO] 2023―Aug―24 New Zealand's COVID-19 elimination strategy and mortality patterns Stacey Kung, Thomas Hills, Nethmi Kearns, Richard Beasley
66 [GO] 2023―Aug―17 Ending the HIV pandemic: preparing for the future The Lancet
67 [GO] 2023―Aug―10 Venous insufficiency and acrocyanosis in long COVID: dysautonomia Nafi Iftekhar, Manoj Sivan
68 [GO] 2023―Aug―07 Setbacks in the quest for universal health coverage in Mexico: polarised politics, policy upheaval, and pandemic disruption Felicia Marie Knaul, Hector Arreola-Ornelas, Michael Touchton, Tim McDonald, Merike Blofield, Leticia Avila Burgos, et al. (+11)
69 [GO] 2023―Jul―27 mRNA vaccines do not stop with COVID-19 Jin Zhou, Yu Zhang, Ke Mo, Herbert Newbert, Xicheng Song
70 [GO] 2023―Jul―27 COVID-19 and commerce complicate minimum unit pricing effects on health Nin-Chieh Hsu, Chia-Hao Hsu
71 [GO] 2023―Jul―27 COVID-19 and commerce complicate minimum unit pricing effects on health - Authors' reply Grant MA Wyper, Daniel F Mackay, Catriona Fraser, Jim Lewsey, Mark Robinson, Clare Beeston, Lucie Giles
72 [GO] 2023―Jul―27 Pandemics and the tourism industry: who is in control? Samuel d'Almeida, Thomas Althaus, Dominique Kerouedan
73 [GO] 2023―Jul―27 Pandemics move faster than funders
74 [GO] 2023―Jul―18 The big catch-up in immunisation coverage after the COVID-19 pandemic: progress and challenges to achieving equitable recovery Katherine L O'Brien, Ephrem Lemango
75 [GO] 2023―Jul―05 Addressing inequity: the world needs an ambitious Pandemic Accord Tovar da Silva Nunes, Ahmed Soliman, Kazuho Taguchi, Precious Matsoso, Roland Alexander Driece, Viroj Tangcharoensathien
76 [GO] 2023―Jun―29 Predicting COVID-19 infection risk in people who are immunocompromised by antibody testing Ratna Wijaya, Marina Johnson, Nicola Campbell, Beth Stuart, Adam Kelly, Nicole Tipler, et al. (+10)
77 [GO] 2023―Jun―29 The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019
78 [GO] 2023―Jun―23 Loneliness in the time of COVID-19: an alarming rise Shakshi Priya Giri, Anubhuti Dubey
79 [GO] 2023―Jun―23 Disrespectful language about patients with long COVID Anthony Pelosi
80 [GO] 2023―Jun―19 Independent SARS-CoV-2 staff testing protected academic and health-care institutions in northwest London Chris Bailey, Theo Sanderson, Hermaleigh Townsley, Jacki Goldman, James R M Black, George Young, et al. (+47)
81 [GO] 2023―Jun―15 Backsliding on human rights and equity in the Pandemic Accord Rajat Khosla, David McCoy, Anna Marriot
82 [GO] 2023―Jun―12 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study Chaolin Huang, Lixue Huang, Yeming Wang, Xia Li, Lili Ren, Xiaoying Gu, et al. (+26)
83 [GO] 2023―Jun―10 Retraction and republication: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study The Lancet Editors
84 [GO] 2023―May―26 Learning from serosurveillance for SARS-CoV-2 to inform pandemic preparedness and response Sophie A Müller, Ambrose Agweyu, Olusola A Akanbi, Mary A Alex-Wele, Kokou N Alinon, Rahul K Arora, et al. (+36)
85 [GO] 2023―May―22 No time for complacency on COVID-19 in Europe Antoine Flahault, Alexandra Calmy, Dominique Costagliola, Oxana Drapkina, Isabella Eckerle, Heidi J Larson, et al. (+4)
86 [GO] 2023―May―19 Primary health care: a cornerstone of pandemic prevention, preparedness, response, and recovery Arush Lal, Nina Schwalbe
87 [GO] 2023―May―18 With the COVID-19 PHEIC over, what next? John Zarocostas
88 [GO] 2023―May―18 Tanzania's COVID-19 vaccination strategy: lessons, learning, and execution Sayoki Godfrey Mfinanga, Wangeci Gatei, Florian Tinuga, William Mngupe Patrick Mwengee, Zabulon Yoti, Ntuli Kapologwe, et al. (+3)
89 [GO] 2023―May―12 Reimagining health security and preventing future pandemics: the NUS-Lancet Pandemic Readiness, Implementation, Monitoring, and Evaluation Commission Helena Legido-Quigley, Helen Clark, Sania Nishtar, Richard Horton
90 [GO] 2023―May―11 The future of nursing: lessons from a pandemic The Lancet
91 [GO] 2023―May―09 The shared ethical framework to allocate scarce medical resources: a lesson from COVID-19 Ezekiel J Emanuel, Govind Persad
92 [GO] 2023―May―04 Eloise Todd: mobilising civil society for pandemic prevention Udani Samarasekera
93 [GO] 2023―Apr―27 Moving past the COVID-19 emergency in the USA The Lancet
94 [GO] 2023―Apr―27 COVID-19: forgetting a pandemic that is not over Jane Galvão
95 [GO] 2023―Apr―27 Moving towards a precision approach for prevention of severe COVID-19 - Authors' reply Utkarsh Agrawal, Chris Robertson, Aziz Sheikh
96 [GO] 2023―Apr―27 The Pandemic Fund-towards equitable financing for pandemics Nelson Aghogho Evaborhene
97 [GO] 2023―Apr―27 The importance of accountability in tackling future pandemics José Szapocznik, Guilherme Faviero, Akua S Dansua, Daniel G Bausch, Jorge Saavedra
98 [GO] 2023―Apr―27 Moving towards a precision approach for prevention of severe COVID-19 Westyn Branch-Elliman, Paul A Monach
99 [GO] 2023―Apr―21 Offline: The UK COVID-19 Inquiry-be patient, but don’t wait Richard Horton
100 [GO] 2023―Apr―21 State-to-state differences in US COVID-19 outcomes: searching for explanations Nicole Lurie, Joshua M Sharfstein
101 [GO] 2023―Apr―21 Lessons learned from COVID-19 to stop future pandemics Thomas Cueni
102 [GO] 2023―Apr―18 Indigenous health-care sovereignty defines resilience to the COVID-19 pandemic Andrey N Petrov, Dalee Sambo Dorough, Sweta Tiwari, Mark Welford, Nikolay Golosov, Michele Devlin, et al. (+3)
103 [GO] 2023―Apr―14 Differential diagnosis of blue toes in a newborn baby: might have been maternal infection with COVID-19? Christoph Hochmayr, Michael Auckenthaler, Franz-Martin Fink, Ursula Kiechl-Kohlendorfer, Elke Griesmaier
104 [GO] 2023―Apr―14 Calls for transparency in pandemic accord talks Talha Burki
105 [GO] 2023―Apr―13 Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, Joshua Abbas, Kasim Abbas, Mustafa Abbas, et al. (+8101)
106 [GO] 2023―Apr―13 Higher-dose dexamethasone for patients with COVID-19 and hypoxaemia? Anders Perner, Balasubramanian Venkatesh
107 [GO] 2023―Apr―05 A WHO pandemic instrument: substantive provisions required to address global shortcomings Roland Alexander Driece, Precious Matsoso, Tovar da Silva Nunes, Ahmed Soliman, Kazuho Taguchi, Viroj Tangcharoensathien
108 [GO] 2023―Mar―31 Retraction-Chinese medical personnel after the COVID-19 pandemic The Editors of The Lancet
109 [GO] 2023―Mar―23 Assessing COVID-19 pandemic policies and behaviours and their economic and educational trade-offs across US states from Jan 1, 2020, to July 31, 2022: an observational analysis Thomas J Bollyky, Emma Castro, Aleksandr Y Aravkin, Kayleigh Bhangdia, Jeremy Dalos, Erin N Hulland, et al. (+52)
110 [GO] 2023―Mar―23 Chinese medical personnel after the COVID-19 pandemic Liyang Sun, Hangdong Jia, Tian Yang
111 [GO] 2023―Mar―09 International cooperation to end the COVID-19 pandemic Zhi Qu
112 [GO] 2023―Mar―09 Long COVID: 3 years in The Lancet
113 [GO] 2023―Mar―02 Confronting the evolution and expansion of anti-vaccine activism in the USA in the COVID-19 era Richard M Carpiano, Timothy Callaghan, Renee DiResta, Noel T Brewer, Chelsea Clinton, Alison P Galvani, et al. (+15)
114 [GO] 2023―Mar―02 Healing Long Covid: a marathon not a sprint Nisreen A Alwan
115 [GO] 2023―Feb―23 China's COVID-19 reopening measures-warriors and weapons Shujie Huang, Zhen Gao, Sichao Wang
116 [GO] 2023―Feb―16 COVID-19 infection, reinfection, and the transition to endemicity Cheryl Cohen, Juliet Pulliam
117 [GO] 2023―Feb―16 Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis Caroline Stein, Hasan Nassereldine, Reed J D Sorensen, Joanne O Amlag, Catherine Bisignano, Sam Byrne, et al. (+20)
118 [GO] 2023―Feb―09 So far, no novel SARS-CoV-2 variants from Beijing-and hopefully better scientific cooperation going forward Wolfgang Preiser, Tongai Maponga
119 [GO] 2023―Feb―09 Characterisation of SARS-CoV-2 variants in Beijing during 2022: an epidemiological and phylogenetic analysis Yang Pan, Liang Wang, Zhaomin Feng, Hui Xu, Fu Li, Ying Shen, et al. (+4)
120 [GO] 2023―Feb―09 Conflicting COVID-19 excess mortality estimates Jonas Schöley, Ariel Karlinsky, Dmitry Kobak, Charles Tallack
121 [GO] 2023―Feb―09 Conflicting COVID-19 excess mortality estimates Alberto Donzelli
122 [GO] 2023―Feb―09 Conflicting COVID-19 excess mortality estimates Peter Bager, Jens Nielsen, Samir Bhatt, Lise Birk Nielsen, Tyra Grove Krause, Lasse Skafte Vestergaard
123 [GO] 2023―Feb―09 Conflicting COVID-19 excess mortality estimates Matshidiso Moeti, Lindiwe Makubalo, Abdou Salam Gueye, Thierno Balde, Humphrey Karamagi, Gordon Awandare, et al. (+4)
124 [GO] 2023―Feb―09 Conflicting COVID-19 excess mortality estimates Desmond O'Neill
125 [GO] 2023―Feb―09 Conflicting COVID-19 excess mortality estimates - Authors' reply Simon I Hay, Christopher J L Murray
126 [GO] 2023―Feb―02 China needs a scientific long COVID recovery-support platform Hao Tan, Jiayan Liu, Fanrui Zeng
127 [GO] 2023―Jan―31 Independent monitoring for the pandemic accord: a non-negotiable provision Layth Hanbali, Susanna Lehtimaki, Elliot Hannon, Christine McNab, Nina Schwalbe
128 [GO] 2023―Jan―18 COVID-19 vaccination is effective at preventing severe illness and complications during pregnancy Sascha Ellington, Tara C Jatlaoui
129 [GO] 2023―Jan―13 COVID-19 and other pandemics require a coherent response strategy Michael G Baker, David Durrheim, Li Yang Hsu, Nick Wilson
130 [GO] 2023―Jan―12 The COVID-19 pandemic in 2023: far from over The Lancet
131 [GO] 2022―Dec―22 Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial Christopher C Butler, F D Richard Hobbs, Oghenekome A Gbinigie, Najib M Rahman, Gail Hayward, Duncan B Richards, et al. (+129)
132 [GO] 2022―Dec―22 Uptake of monoclonal antibodies and antiviral therapies for COVID-19 in Scotland Holly Tibble, Tanja Mueller, Euan Proud, Elliott Hall, Amanj Kurdi, Chris Robertson, et al. (+3)
133 [GO] 2022―Dec―22 PANORAMIC: important insights into molnupiravir use in COVID-19 Michael R Kidd, Paul M Kelly
134 [GO] 2022―Dec―15 Louis Pasteur, COVID-19, and the social challenges of epidemics Tamara Giles-Vernick, Phaik Yeong Cheah, Gustavo Matta, Nisia Trindade Lima
135 [GO] 2022―Dec―14 Community pandemic response: the importance of action led by communities and the public sector Winnie Byanyima, Karl Lauterbach, Matthew M Kavanagh
136 [GO] 2022―Dec―02 Integrated respiratory surveillance after the COVID-19 pandemic William Elson, Maria Zambon, Simon de Lusignan
137 [GO] 2022―Nov―25 Bayesian reconstruction of household transmissions to infer the serial interval of COVID-19 by variants of concern: analysis from a prospective community cohort study (Virus Watch) Cyril Geismar, Vincent Nguyen, Ellen Fragaszy, Madhumita Shrotri, Annalan M D Navaratnam, Sarah Beale, et al. (+10)
138 [GO] 2022―Nov―25 COVID-19 and the role of Voluntary, Community, and Social Enterprises in northern England in responding to the needs of marginalised communities: a qualitative focus group study Stephanie Scott, Victoria J McGowan, Josephine M Wildman, Elaine Bidmead, Jane Hartley, Claire Mathews, et al. (+4)
139 [GO] 2022―Nov―25 Expression of concern: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study The Lancet Editors
140 [GO] 2022―Nov―25 The effect of indoor soundscape on sexual wellbeing during the COVID-19 lockdown in London: a thematic analysis of remote workers' experiences Simone Torresin, Eleanor Ratcliffe, Francesco Aletta, Rossano Albatici, Francesco Babich, Tin Oberman, Jian Kang
141 [GO] 2022―Nov―25 How did living in temporary accommodation during the COVID-19 pandemic affect children younger than 5 years' access to health care and health outcomes? A qualitative study of key professionals in a socially and ethnically diverse and deprived area of London Diana Margot Rosenthal, Michelle Heys, Antoinette Schoenthaler, Andrew Hayward, Marcella Ucci, Celine Lewis
142 [GO] 2022―Nov―25 Changes in online food access during the COVID-19 pandemic and associations with deprivation: a longitudinal analysis Matthew Keeble, Jean Adams, Thomas Burgoine
143 [GO] 2022―Nov―25 Engagement of individuals aged 14-25 years with a digital mental health service during the COVID-19 pandemic in the UK: a cohort study of service usage data Aynsley Bernard, Louisa Salhi, Santiago de Ossorno Garcia, Ann John, Marcos del Pozo-Baños
144 [GO] 2022―Nov―25 Experience of homelessness during the COVID-19 pandemic in Tower Hamlets, London: a health needs assessment Sam Tweed
145 [GO] 2022―Nov―25 Effect of the COVID-19 pandemic on incidence of long-term conditions in Welsh residents: a population linkage study Cathy Qi, Timothy Osborne, Rowena Bailey, Joe Hollinghurst, Ashley Akbari, Alison Cooper, et al. (+5)
146 [GO] 2022―Nov―25 The impact of the COVID-19 pandemic on people experiencing homelessness: a qualitative interview study in the UK Jo Dawes, Tom May, Daisy Fancourt, Alexandra Burton
147 [GO] 2022―Nov―25 Mental health of the nursing and midwifery workforce in Wales during the COVID-19 pandemic: a cross-sectional analysis Benjamin J Gray, Richard G Kyle, Aimée Challenger, Alisha R Davies
148 [GO] 2022―Nov―25 Shifting priorities and employment choices among workers in Wales during the COVID-19 pandemic: a longitudinal analysis Melda Lois Griffiths, Benjamin J Gray, Richard G Kyle, Alisha R Davies
149 [GO] 2022―Nov―25 Impact of the temporary suspension of the Bowel Screening Wales programme on inequalities during the COVID-19 pandemic: a retrospective register-based study Diana Bright, Jiao Song, Sharon Hillier, Dyfed W Huws, Giles Greene, Karen Hodgson, et al. (+4)
150 [GO] 2022―Nov―25 How did female survivors of abuse use the arts to support their mental health and wellbeing during the COVID-19 pandemic? A qualitative exploration of their views Alison R McKinlay, Lorna Collins, Daisy Fancourt, Alexandra Burton
151 [GO] 2022―Nov―25 COVID-19 vaccination uptake for half a million non-EU migrants and refugees in England: a linked retrospective population-based cohort study Rachel Burns, Ines Campos-Matos, Katie Harron, Robert W Aldridge
152 [GO] 2022―Nov―25 Implementing behavioural science informed letter interventions to increase COVID-19 vaccination uptake in uncontactable London residents: a difference-in-difference study in London, UK Sarah W Huf, Lena Woldmann, Roberto Fernandez Crespo, Kate Grailey, Bahram Hassanpourfard, Matthew Chisambi, et al. (+4)
153 [GO] 2022―Nov―25 The UK's Free School Meals policy during the pandemic: a thematic content analysis of policy documents and debates Jennie C Parnham, Eszter P Vamos, Sarah McKevitt, Anthony A Laverty
154 [GO] 2022―Nov―25 The prevalence of stigma in a UK community survey of people with lived experience of long COVID Marija Pantelic, Nida Zia�n, Mark Boyes, Margaret E O'Hara, Claire Hastie, Nisreen A Alwan
155 [GO] 2022―Nov―17 Human rights and the COVID-19 pandemic: a retrospective and prospective analysis Lawrence O Gostin, Eric A Friedman, Sara Hossain, Joia Mukherjee, Saman Zia-Zarifi, Chelsea Clinton, et al. (+4)
156 [GO] 2022―Nov―17 Offline: COVID-19-the lessons that science forgot Richard Horton
157 [GO] 2022―Nov―17 US CDC begins agency-wide changes after pandemic failures Susan Jaffe
158 [GO] 2022―Nov―10 WHO Living Guidelines on antivirals for COVID-19 are evidence-based Andrew Owen, Janet Victoria Diaz, Gordon Guyatt, François Lamontagne, Miriam Stegemann, Per Olav Vandvik, Thomas Agoritsas
159 [GO] 2022―Oct―27 COVID-19 and other adult vaccines can drive global disease prevention David B Agus, Aurélia Nguyen, Amadou Alpha Sall, John Bell
160 [GO] 2022―Oct―27 Challenges and opportunities for educating health professionals after the COVID-19 pandemic Julio Frenk, Lincoln C Chen, Latha Chandran, Elizabeth O H Groff, Roderick King, Afaf Meleis, Harvey V Fineberg
161 [GO] 2022―Oct―27 Pandemic solidarity across national borders saved lives Mitali Das, Kieren Keke
162 [GO] 2022―Oct―26 The legacy of the COVID-19 pandemic for childhood vaccination in the USA Douglas J Opel, Noel T Brewer, Alison M Buttenheim, Timothy Callaghan, Richard M Carpiano, Chelsea Clinton, et al. (+15)
163 [GO] 2022―Oct―24 After 2 years of the COVID-19 pandemic, translating One Health into action is urgent Thierry Lefrançois, Denis Malvy, Laetitia Atlani-Duault, Daniel Benamouzig, Pierre-Louis Druais, Yazdan Yazdanpanah, et al. (+2)
164 [GO] 2022―Oct―14 Prioritisation of COVID-19 boosters in the omicron era Stephanie A Irving, Maria E Sundaram
165 [GO] 2022―Oct―14 Resistance to COVID-19 controls in an anthropologist's home town Mary T Bassett
166 [GO] 2022―Oct―14 Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales Utkarsh Agrawal, Stuart Bedston, Colin McCowan, Jason Oke, Lynsey Patterson, Chris Robertson, et al. (+21)
167 [GO] 2022―Oct―14 Reconsidering the COVID-19 vaccine strategy in West and Central Africa Philippe Msellati, Khoudia Sow, Alice Desclaux, Gilles Cottrell, Mamadou Diallo, Jean-Yves Le Hesran, et al. (+4)
168 [GO] 2022―Oct―07 Real-world effectiveness of oral antivirals for COVID-19 Charles Burdet, Florence Ader
169 [GO] 2022―Oct―07 A reinvigorated multilateralism in health: lessons and innovations from the COVID-19 pandemic Julio Frenk, Tore Godal, Octavio Gómez-Dantés, Jonas Gahr Store
170 [GO] 2022―Oct―07 Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: an observational study Carlos K H Wong, Ivan C H Au, Kristy T K Lau, Eric H Y Lau, Benjamin J Cowling, Gabriel M Leung
171 [GO] 2022―Oct―06 WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessed Mary Y Wu, Edward J Carr, Ruth Harvey, Harriet V Mears, Svend Kjaer, Hermaleigh Townsley, et al. (+13)
172 [GO] 2022―Sep―22 Characterising adults in Scotland who are not vaccinated against COVID-19 Safraj Shahul Hameed, Elliott Hall, Zoe Grange, Christopher Sullivan, Sharon Kennedy, Lewis D Ritchie, et al. (+8)
173 [GO] 2022―Sep―14 The Lancet Commission on lessons for the future from the COVID-19 pandemic Jeffrey D Sachs, Salim S Abdool Karim, Lara Aknin, Joseph Allen, Kirsten Brosbøl, Francesca Colombo, et al. (+34)
174 [GO] 2022―Sep―14 COVID-19: the case for prosociality The Lancet
175 [GO] 2022―Sep―08 Misclassification bias in estimating clinical severity of SARS-CoV-2 variants Christina Yek, Sarah Warner, Alex Mancera, Sameer S Kadri
176 [GO] 2022―Sep―08 Misclassification bias in estimating clinical severity of SARS-CoV-2 variants - Authors' reply Tommy Nyberg, Neil M Ferguson, Joshua Blake, Wes Hinsley, Samir Bhatt, Daniela De Angelis, et al. (+2)
177 [GO] 2022―Sep―01 Protecting older people: a high priority during the COVID-19 pandemic Yifei Zhang, Yufan Wang, Guang Ning, Ping He, Weiqing Wang
178 [GO] 2022―Sep―01 New centre for pandemic therapeutics Jacqui Thornton
179 [GO] 2022―Aug―26 Trust made the difference for democracies in COVID-19 Thomas J Bollyky, Olivia Angelino, Simon Wigley, Joseph L Dieleman
180 [GO] 2022―Aug―26 Forgetting pandemics may be hazardous to your health Howard Markel
181 [GO] 2022―Aug―04 COVID-19 and microbiome diversity in sub-Saharan Africa Wim Van Damme, Richard Wamai, Yibeltal Assefa, Laurens Liesenborghs, Dieudonné Mumba
182 [GO] 2022―Aug―04 COVID-19 and microbiome diversity in sub-Saharan Africa - Author's reply Reed J D Sorensen
183 [GO] 2022―Aug―04 Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study Aranka V Ballering, Sander K R van Zon, Tim C olde Hartman, Judith G M Rosmalen
184 [GO] 2022―Aug―04 Long COVID: which symptoms can be attributed to SARS-CoV-2 infection? Christopher E Brightling, Rachael A Evans
185 [GO] 2022―Aug―04 Global pandemic perspectives: public health, mental health, and lessons for the future Matshidiso Moeti, George F Gao, Helen Herrman
186 [GO] 2022―Jul―28 Violence against health workers rises during COVID-19 Jacqui Thornton
187 [GO] 2022―Jul―28 Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Obbina Abani, Ali Abbas, Fatima Abbas, Joshua Abbas, Kasim Abbas, Mustafa Abbas, et al. (+7936)
188 [GO] 2022―Jul―28 Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing mortality Puja Mehta, Boghuma K Titanji
189 [GO] 2022―Jul―18 The UK COVID-19 Inquiry must examine the foundations of pandemic decision making Tom Lawton, Nisreen A Alwan
190 [GO] 2022―Jul―14 Preparing for uncertainty: endemic paediatric viral illnesses after COVID-19 pandemic disruption Kevin Messacar, Rachel E Baker, Sang Woo Park, Hai Nguyen-Tran, Jessica R Cataldi, Bryan Grenfell
191 [GO] 2022―Jul―11 Perilous two-tier COVID-19 global vaccine roll-out David N Durrheim
192 [GO] 2022―Jul―08 Effectiveness of vaccination mandates in improving uptake of COVID-19 vaccines in the USA Michelle M Mello, Douglas J Opel, Regina M Benjamin, Timothy Callaghan, Renee DiResta, Jad A Elharake, et al. (+14)
193 [GO] 2022―Jul―06 Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa Ameena Goga, Linda-Gail Bekker, Nigel Garrett, Tarylee Reddy, Nonhlanhla Yende-Zuma, Lara Fairall, et al. (+7)
194 [GO] 2022―Jul―01 Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy: a retrospective analysis of January-April, 2022 Chiara Sacco, Martina Del Manso, Alberto Mateo-Urdiales, Maria Cristina Rota, Daniele Petrone, Flavia Riccardo, et al. (+11)
195 [GO] 2022―Jul―01 COVID-19 vaccination for children aged 5-11 years Shamez N Ladhani
196 [GO] 2022―Jul―01 Shifting gender barriers in immunisation in the COVID-19 pandemic response and beyond Tiffany Nassiri-Ansari, Phionah Atuhebwe, Akosua Sika Ayisi, Sarah Goulding, Mira Johri, Pascale Allotey, Nina Schwalbe
197 [GO] 2022―Jul―01 Monkeypox genomic surveillance will challenge lessons learned from SARS-CoV-2 Florian Pfaff, Donata Hoffmann, Martin Beer
198 [GO] 2022―Jun―29 A new paradigm is needed for financing the pandemic fund Simon Reid-Henry, Jon Lidén, Christoph Benn, Diah Saminarsih, Olivia Herlinda, María Fernanda Bustos Venegas
199 [GO] 2022―Jun―23 COVID-19 in North Korea Talha Burki
200 [GO] 2022―Jun―16 Memorialising COVID-19 Danielle Ofri
201 [GO] 2022―Jun―16 Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2 Michela Antonelli, Joan Capdevila Pujol, Tim D Spector, Sebastien Ourselin, Claire J Steves
202 [GO] 2022―Jun―10 COVID-19 mRNA vaccination and myocarditis or pericarditis Anders Husby, Lars Køber
203 [GO] 2022―Jun―10 Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases Hui-Lee Wong, Mao Hu, Cindy Ke Zhou, Patricia C Lloyd, Kandace L Amend, Daniel C Beachler, et al. (+18)
204 [GO] 2022―Jun―10 Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial Grace Li, Federica Cappuccini, Natalie G Marchevsky, Parvinder K Aley, Robert Aley, Rachel Anslow, et al. (+65)
205 [GO] 2022―Jun―10 Increasing children's global access to COVID-19 vaccines Manish Patel, Minal Patel
206 [GO] 2022―May―30 Pandemic preparedness means policy makers need to work with social scientists Martyn Pickersgill, Lucinda Manda-Taylor, Natalia Niño-Machado
207 [GO] 2022―May―25 COVID-19 boosters and building trust among UK minority ethnic communities Laura B Nellums, Asam Latif, Kennedy Nkhoma, Stephen Timmons, Manish Pareek, Salma Almidani, Basharat Hussain
208 [GO] 2022―May―19 Where is the next SARS-CoV-2 variant of concern? John J Dennehy, Ravindra K Gupta, William P Hanage, Marc C Johnson, Thomas P Peacock
209 [GO] 2022―May―19 Offline: How to fix pandemic preparedness Richard Horton
210 [GO] 2022―May―18 Transforming or tinkering: the world remains unprepared for the next pandemic threat Helen Clark, Mauricio Cardenas, Mark Dybul, Michel Kazatchkine, Joanne Liu, David Miliband, et al. (+10)
211 [GO] 2022―May―12 Raj Panjabi: bringing a global outlook to the US pandemic response Susan Jaffe
212 [GO] 2022―May―06 Counting the global COVID-19 dead Prabhat Jha, Patrick E Brown, Rashid Ansumana
213 [GO] 2022―May―06 Shanghai's life-saving efforts against the current omicron wave of the COVID-19 pandemic Xinxin Zhang, Wenhong Zhang, Saijuan Chen
214 [GO] 2022―May―05 COVID-19 and inter-generational solidarity Peter Lloyd Sherlock
215 [GO] 2022―May―05 COVID-19: the next phase and beyond The Lancet
216 [GO] 2022―May―05 A global view of the pandemic: the good, bad, and ugly Philip Ball
217 [GO] 2022―May―02 Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
218 [GO] 2022―Apr―28 Africa CDC warns COVID-19 vaccine production could cease Paul Adepoju
219 [GO] 2022―Apr―28 Finding hope in two pandemics Ofole Mgbako
220 [GO] 2022―Apr―25 Responding to the humanitarian crisis of the war in Ukraine with lessons from COVID-19 David Archard, Alena Buyx, Jean-François Delfraissy
221 [GO] 2022―Apr―21 Transforming the UK's diagnostics agenda after COVID-19 Dimitris K Grammatopoulos, Lawrence Young, Neil R Anderson
222 [GO] 2022―Apr―14 Cracks in the foundation: how COVID-19 showed our failures Mary T Bassett
223 [GO] 2022―Apr―14 Advancing accurate metrics for future pandemic preparedness Francine Ntoumi, Alimuddin Zumla
224 [GO] 2022―Apr―11 What comes next in the COVID-19 pandemic? Dale Fisher, Sameera Suri, Gail Carson
225 [GO] 2022―Apr―08 How to interpret the total number of SARS-CoV-2 infections Kayoko Shioda, Ben Lopman
226 [GO] 2022―Apr―08 Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis Ryan M Barber, Reed J D Sorensen, David M Pigott, Catherine Bisignano, Austin Carter, Joanne O Amlag, et al. (+66)
227 [GO] 2022―Apr―07 SARS-CoV-2 nucleic acid testing is China's key pillar of COVID-19 containment Xiaoxu Han, Jinming Li, Yu Chen, Yan Li, Yingchun Xu, Binwu Ying, Hong Shang
228 [GO] 2022―Apr―07 COVID-19 vaccination and HIV-1 acquisition Denis Y Logunov, David M Livermore, David A Ornelles, Wibke Bayer, Ernesto Marques, Cecil Czerkinsky, et al. (+2)
229 [GO] 2022―Apr―07 COVID-19 vaccination and HIV-1 acquisition - Authors’ reply Susan P Buchbinder, M Juliana McElrath, Carl Dieffenbach, Lawrence Corey
230 [GO] 2022―Apr―07 Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study Cristina Menni, Ana M Valdes, Lorenzo Polidori, Michela Antonelli, Satya Penamakuri, Ana Nogal, et al. (+18)
231 [GO] 2022―Mar―31 DNA vaccines join the fight against COVID-19 Anna K Blakney, Linda-Gail Bekker
232 [GO] 2022―Mar―31 Mixed response to COVID-19 intellectual property waiver John Zarocostas
233 [GO] 2022―Mar―31 Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India Akash Khobragade, Suresh Bhate, Vijendra Ramaiah, Shrikant Deshpande, Krishna Giri, Himanshu Phophle, et al. (+9)
234 [GO] 2022―Mar―25 Booster vaccines for COVID-19 vaccine breakthrough cases? Douglas F Nixon, Robert E Schwartz, Lishomwa C Ndhlovu
235 [GO] 2022―Mar―25 Booster vaccines for COVID-19 vaccine breakthrough cases? - Authors' reply Philip R Krause, Helen Rees, J Peter Figueroa, Soumya Swaminathan, Ana Maria Henao Restrepo
236 [GO] 2022―Mar―25 Strengthening public mental health during and after the acute phase of the COVID-19 pandemic Lola Kola, Manasi Kumar, Brandon A Kohrt, Tobi Fatodun, Bisola A Olayemi, Adeyinka O Adefolarin
237 [GO] 2022―Mar―25 SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses Maaike C Swets, Clark D Russell, Ewen M Harrison, Annemarie B Docherty, Nazir Lone, Michelle Girvan, et al. (+6)
238 [GO] 2022―Mar―25 Host-targeting oral antiviral drugs to prevent pandemics Raymond A Dwek, John I Bell, Marc Feldmann, Nicole Zitzmann
239 [GO] 2022―Mar―22 Ritonavir and COVID-19: pragmatic guidance is important Laura Waters, Fiona Marra, Anton Pozniak, James Cockburn, Marta Boffito
240 [GO] 2022―Mar―16 Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study Tommy Nyberg, Neil M Ferguson, Sophie G Nash, Harriet H Webster, Seth Flaxman, Nick Andrews, et al. (+46)
241 [GO] 2022―Mar―15 Effectiveness of rAd26-rAd5, ChAdOx1 nCoV-19, and BBIBP-CorV vaccines for risk of infection with SARS-CoV-2 and death due to COVID-19 in people older than 60 years in Argentina: a test-negative, case-control, and retrospective longitudinal study Analía Rearte, Juan Manuel Castelli, Ramiro Rearte, Nora Fuentes, Velen Pennini, Martina Pesce, et al. (+11)
242 [GO] 2022―Mar―15 Evaluating COVID-19 vaccines in the real world Edward J Mills, Gilmar Reis
243 [GO] 2022―Mar―10 Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21 Haidong Wang, Katherine R Paulson, Spencer A Pease, Stefanie Watson, Haley Comfort, Peng Zheng, et al. (+90)
244 [GO] 2022―Mar―10 Transmission of SARS-CoV-2 delta variant (AY.127) from pet hamsters to humans, leading to onward human-to-human transmission: a case study Hui-Ling Yen, Thomas H C Sit, Christopher J Brackman, Shirley S Y Chuk, Haogao Gu, Karina W S Tam, et al. (+19)
245 [GO] 2022―Mar―10 Spreading of SARS-CoV-2 from hamsters to humans Bart L Haagmans, Marion P G Koopmans
246 [GO] 2022―Mar―03 Quantifying the effects of the COVID-19 pandemic on gender equality on health, social, and economic indicators: a comprehensive review of data from March, 2020, to September, 2021 Luisa S Flor, Joseph Friedman, Cory N Spencer, John Cagney, Alejandra Arrieta, Molly E Herbert, et al. (+16)
247 [GO] 2022―Mar―03 Brazil's COVID-19 guidelines: political hijack of public health Luis C L Correia, Cristina Sette, Marisa Santos, Carlos A S Magliano, Fotini S Toscas
248 [GO] 2022―Mar―02 Gender equality and COVID-19: act now before it is too late Rosemary Morgan, Denise Nacif Pimenta, Sabina Rashid
249 [GO] 2022―Mar―02 Travel measures in the SARS-CoV-2 variant era need clear objectives Adam J Kucharski, Mark Jit, James G Logan, Matthew Cotten, Samuel Clifford, Billy J Quilty, et al. (+4)
250 [GO] 2022―Feb―24 Understanding of COVID-19 from infection-fatality ratio Xiaoying Gu, Bin Cao
251 [GO] 2022―Feb―24 Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis
252 [GO] 2022―Feb―24 The global COVID-19 treatment divide Ann Danaiya Usher
253 [GO] 2022―Feb―24 Waning effectiveness of COVID-19 vaccines Hiam Chemaitelly, Laith J Abu-Raddad
254 [GO] 2022―Feb―23 Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression Daniel R Feikin, Melissa M Higdon, Laith J Abu-Raddad, Nick Andrews, Rafael Araos, Yair Goldberg, et al. (+8)
255 [GO] 2022―Feb―23 Waning of COVID-19 vaccine effectiveness: individual and public health risk Vanessa Piechotta, Thomas Harder
256 [GO] 2022―Feb―18 Decoupling of omicron variant infections and severe COVID-19 Shabir A Madhi, Chikwe Ihekweazu, Helen Rees, Andrew J Pollard
257 [GO] 2022―Feb―18 COVID-19 booster doses in pregnancy and global vaccine equity Erkan Kalafat, Laura A Magee, Peter von Dadelszen, Paul Heath, Asma Khalil
258 [GO] 2022―Feb―16 Children, intersectionality, and COVID-19 Katy Dineen, Bengt Autzen, Nisreen A Alwan
259 [GO] 2022―Feb―10 Offline: Complacency threatens progress against COVID-19 Richard Horton
260 [GO] 2022―Feb―10 The vaccinated propor-tion of people with COVID-19 needs context Sam Egger, Garry Egger
261 [GO] 2022―Feb―10 Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, Mustafa Abbas, Sadia Abbasi, Hakam Abbass, et al. (+6297)
262 [GO] 2022―Feb―10 Another piece in the COVID-19 treatment puzzle Cristina Mussini, Alessandro Cozzi-Lepri
263 [GO] 2022―Feb―05 Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden Peter Nordström, Marcel Ballin, Anna Nordström
264 [GO] 2022―Feb―03 Depression and anxiety during COVID-19 - Authors' reply Damian F Santomauro, Harvey A Whiteford, Alize J Ferrari
265 [GO] 2022―Feb―03 Depression and anxiety during COVID-19 Michael Daly, Eric Robinson
266 [GO] 2022―Feb―03 COVID-19 in Europe: new challenges for addressing vaccine hesitancy Emilie Karafillakis, Pierre Van Damme, Greet Hendrickx, Heidi J Larson
267 [GO] 2022―Feb―03 WHO concerned over COVID-19 health-care waste John Zarocostas
268 [GO] 2022―Feb―03 Ayoade Alakija: advancing equity in the COVID-19 response Udani Samarasekera
269 [GO] 2022―Feb―03 Transmission of SARS-CoV-2: still up in the air Alison Lopez, Jocelyn Srigley
270 [GO] 2022―Feb―03 Transmission of SARS-CoV-2: still up in the air - Authors' reply Trisha Greenhalgh, Jose L Jimenez, Kimberly A Prather, Zeynep Tufeki, David Fisman, Robert Schooley
271 [GO] 2022―Feb―03 Xenophobia, prejudice, and blame in pandemic times Alexandre I R White
272 [GO] 2022―Feb―02 Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021 Thomas J Bollyky, Erin N Hulland, Ryan M Barber, James K Collins, Samantha Kiernan, Mark Moses, et al. (+79)
273 [GO] 2022―Jan―28 Polish Government COVID-19 advisors resign Ed Holt
274 [GO] 2022―Jan―28 High-dose immunoglobulins from convalescent donors for patients hospitalised with COVID-19 Cynthia So-Osman, Sarah J Valk
275 [GO] 2022―Jan―28 Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial Mark N. Polizzotto, Jacqueline Nordwall, Abdel G. Babiker, Andrew Phillips, David M. Vock, Nnakelu Eriobu, et al. (+82)
276 [GO] 2022―Jan―28 Offline: Sex and power during a pandemic Richard Horton
277 [GO] 2022―Jan―28 Urgent care: disability, pandemic, and the value of a life Rachel Adams
278 [GO] 2022―Jan―25 Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer Annika Fendler, Scott T C Shepherd, Lewis Au, Mary Wu, Ruth Harvey, Andreas M Schmitt, et al. (+55)
279 [GO] 2022―Jan―21 Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study Sue Ann Costa Clemens, Lily Weckx, Ralf Clemens, Ana Verena Almeida Mendes, Alessandra Ramos Souza, Mariana B V Silveira, et al. (+40)
280 [GO] 2022―Jan―20 Recognising Italy's mistakes in the public health response to COVID-19 Chiara Alfieri, Marc Egrot, Alice Desclaux, Kelley Sams
281 [GO] 2022―Jan―20 Offline: COVID-19 as culture war Richard Horton
282 [GO] 2022―Jan―20 The COVID-19 response in Hong Kong Tong B Tang
283 [GO] 2022―Jan―20 Omicron neutralising antibodies after COVID-19 vaccination in haemodialysis patients Edward J Carr, Mary Wu, Ruth Harvey, Roseanne E Billany, Emma C Wall, Gavin Kelly, et al. (+11)
284 [GO] 2022―Jan―20 Trimeric S protein COVID-19 vaccine needs to find its place Timo Vesikari
285 [GO] 2022―Jan―20 Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study Nicole Wolter, Waasila Jassat, Sibongile Walaza, Richard Welch, Harry Moultrie, Michelle Groome, et al. (+22)
286 [GO] 2022―Jan―20 The overlooked pandemic of antimicrobial resistance Ramanan Laxminarayan
287 [GO] 2022―Jan―20 COVID-19 will continue but the end of the pandemic is near Christopher J L Murray
288 [GO] 2022―Jan―20 Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial Lulu Bravo, Igor Smolenov, Htay Htay Han, Ping Li, Romana Hosain, Frank Rockhold, et al. (+41)
289 [GO] 2022―Jan―20 Long COVID and self-management Kirsty Brown, Asma Yahyouche, Shamil Haroon, Jenny Camaradou, Grace Turner
290 [GO] 2022―Jan―18 Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose Constanze Kuhlmann, Carla Konstanze Mayer, Mathilda Claassen, Tongai Maponga, Wendy A Burgers, Roanne Keeton, et al. (+5)
291 [GO] 2022―Jan―13 Disrupted care in Papua New Guinea: the harms of COVID-19 Chris McCall
292 [GO] 2022―Jan―13 Ground glass opacities are not always COVID-19: a case of acute eosinophilic pneumonitis caused by daptomycin Rajalakshmi Valaiyapathi, Meng-San Wu, Alastair McGregor
293 [GO] 2021―Dec―31 COVID-19 ARDS: getting ventilation right - Authors' reply Ryan P Barbaro, Graeme MacLaren, Justyna Swol, Arthur S Slutsky, Daniel Brodie
294 [GO] 2021―Dec―31 COVID-19 ARDS: getting ventilation right Xosé L Pérez-Fernández, Joan Sabater-Riera, MariPaz Fuset-Cabanes
295 [GO] 2021―Dec―31 Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management Joseph Heskin, Scott J C Pallett, Nabeela Mughal, Gary W Davies, Luke S P Moore, Michael Rayment, Rachael Jones
296 [GO] 2021―Dec―24 Mandatory COVID-19 vaccination and human rights Jeff King, Octávio Luiz Motta Ferraz, Andrew Jones
297 [GO] 2021―Dec―24 Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial Scott A Halperin, Lingyun Ye, Donna MacKinnon-Cameron, Bruce Smith, Pedro E Cahn, Guillermo M Ruiz-Palacios, et al. (+42)
298 [GO] 2021―Dec―24 Efficacy of an adenovirus type 5 vectored SARS-CoV-2 vaccine Richard B Kennedy
299 [GO] 2021―Dec―22 LGBTQ youth mental health during COVID-19: unmet needs in public health and policy Cameron K Ormiston, Faustine Williams
300 [GO] 2021―Dec―20 Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil Srinivasa Vittal Katikireddi, Thiago Cerqueira-Silva, Eleftheria Vasileiou, Chris Robertson, Sarah Amele, Jiafeng Pan, et al. (+18)
301 [GO] 2021―Dec―20 Diagnostics for COVID-19: moving from pandemic response to control Rosanna W Peeling, David L Heymann, Yik-Ying Teo, Patricia J Garcia
302 [GO] 2021―Dec―20 Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum Wanwisa Dejnirattisai, Robert H Shaw, Piyada Supasa, Chang Liu, Arabella SV Stuart, Andrew J Pollard, et al. (+8)
303 [GO] 2021―Dec―20 Managing waning vaccine protection against SARS-CoV-2 variants Kathy Leung, Joseph T Wu
304 [GO] 2021―Dec―16 Projecting COVID-19 disruption to elective surgery COVIDSurg Collaborative
305 [GO] 2021―Dec―16 COVID-19 vaccine strategies must focus on severe disease and global equity Peter B McIntyre, Rakesh Aggarwal, Ilesh Jani, Jaleela Jawad, Sonali Kochhar, Noni MacDonald, et al. (+9)
306 [GO] 2021―Dec―16 COVID-19: where do we go from here? The Lancet
307 [GO] 2021―Dec―15 Anticoagulation in COVID-19 Charlotte A Bradbury, Zoe McQuilten
308 [GO] 2021―Dec―15 Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial Eduardo Ramacciotti, Leandro Barile Agati, Daniela Calderaro, Valéria Cristina Resende Aguiar, Alex C Spyropoulos, Caroline Candida Carvalho de Oliveira, et al. (+38)
309 [GO] 2021―Dec―11 Governing the Access to COVID-19 Tools Accelerator: towards greater participation, transparency, and accountability Suerie Moon, Jana Armstrong, Brian Hutler, Ross Upshur, Rachel Katz, Caesar Atuire, et al. (+12)
310 [GO] 2021―Dec―09 High-dose budesonide for early COVID-19 Brian Lipworth, Rory Chan, Rasads Misirovs
311 [GO] 2021―Dec―09 High-dose budesonide for early COVID-19 Ivan Berezowski, Jigar Patel, Mariame Shaw, Ali Pourmand
312 [GO] 2021―Dec―09 High-dose budesonide for early COVID-19 - Authors' reply F D Richard Hobbs, Ly-Mee Yu, Benjamin R Saville, Mona Bafadhel, Christopher C Butler
313 [GO] 2021―Dec―08 Preparing for future pandemics in the Eastern Mediterranean region Wasiq Khan, Abdinasir Abubakar, Richard J Brennan, Farida Al Hosani, Thoraya Obaid, Anders Nordstrom, Peter Friberg
314 [GO] 2021―Dec―06 Mixing mRNA, adenoviral, and spike-adjuvant vaccines for protection against COVID-19 Christopher D Richardson
315 [GO] 2021―Dec―06 Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial Arabella S V Stuart, Robert H Shaw, Xinxue Liu, Melanie Greenland, Parvinder K Aley, Nick J Andrews, et al. (+37)
316 [GO] 2021―Dec―03 Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic Salim S Abdool Karim, Quarraisha Abdool Karim
317 [GO] 2021―Dec―02 Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial Alasdair P S Munro, Leila Janani, Victoria Cornelius, Parvinder K Aley, Gavin Babbage, David Baxter, et al. (+301)
318 [GO] 2021―Nov―26 Evaluation of the impact of tiered restrictions introduced in England during October and December, 2020, on COVID-19 cases: a synthetic control study Xingna Zhang, Gwilym Owen, Mark Green, Iain Buchan, Ben Barr
319 [GO] 2021―Nov―26 COVID-19 and prepandemic all-cause inequalities in disability-adjusted life-years due to multiple deprivation: a Scottish Burden of Disease study Grant M A Wyper, Eilidh Fletcher, Ian Grant, Oliver Harding, Maria Teresa de Haro Moro, Diane L Stockton, Gerry McCartney
320 [GO] 2021―Nov―26 “It's been up and down”-perspectives on living through COVID-19 for individuals who experience homelessness: a qualitative study Emma A Adams, Jeff Parker, Tony Jablonski, Joanne Kennedy, Desmond Hunter, Fiona Tasker, et al. (+9)
321 [GO] 2021―Nov―26 SARS-CoV-2 testing, infections, and hospital admissions with COVID-19 in children and young people in Scotland: a birth cohort study Graziella Favarato, Linda Wijlaars, Tom Clemens, Steve Cunningham, Bianca De Stavola, Chris Dibben, et al. (+7)
322 [GO] 2021―Nov―26 The severity of COVID-19 infection in patients with anorexia nervosa: an observational study Michael J Taylor, Uju Okereke, Robert Wilson, Anthony Winston
323 [GO] 2021―Nov―26 An exploration of the uptake of asymptomatic COVID-19 lateral flow testing in Birmingham, UK: cross-sectional survey and qualitative analysis Jonathan Mathers, Christopher Poyner, Dean Thompson, Gavin Rudge, Ruth Pritchett
324 [GO] 2021―Nov―26 Resilience of elective cancer surgery systems during COVID-19 lockdowns: an international, multicentre, prospective cohort study
325 [GO] 2021―Nov―26 Attitudes towards COVID-19 mitigation measures implemented at St Mark's Bowel Cancer Screening Centre: a cross-sectional analysis of survey data from an ethnically diverse region in London Andrew Prentice, Ghalial Kayal, Sarah Marshall, Christian von Wagner, Robert S Kerrison
326 [GO] 2021―Nov―26 Measuring the impact of COVID-19 on sexual and reproductive health in the UK: web-panel surveys with qualitative follow-up Nigel Field, Emily Dema, Andrew J Copas, Soazig Clifton, Anne Conolly, Margaret Blake, et al. (+8)
327 [GO] 2021―Nov―26 Individuals with lived experience of homelessness and their COVID-19 outcomes in Wales: a data linkage study Jiao Song, Chris Moreno-Stokoe, Charlotte Grey, Alisha R Davies
328 [GO] 2021―Nov―26 Health protocol compliance integrated monitoring system to inform public health actions during the COVID-19 pandemic in Indonesia Dewi Nur Aisyah, Thifal Kiasatina, Gayatri I Gusti, Wiku Adisasmito, Logan Manikam, Zisis Kozlakidis
329 [GO] 2021―Nov―26 Population birth outcomes and experiences of expectant mothers during the COVID-19 pandemic in Wales: a mixed methods study Hope Jones, Mike Seaborne, Laura Cowley, David Odd, Shantini Paranjothy, Ashley Akbari, Sinead Brophy
330 [GO] 2021―Nov―26 Community-led action in response to the COVID-19 pandemic in Wales: a national, cross-sectional survey Charlotte N B Grey, Lucia Homolova, Alisha Davies
331 [GO] 2021―Nov―26 Impact of the COVID-19 pandemic on health-care usage and mental health of clinically extremely vulnerable individuals in Wales: a population-scale data linkage study Alisha Davies, Jiao Song, Ashley Akbari, Laura Bentley, Bethan Carter, Lynsey Cross, et al. (+6)
332 [GO] 2021―Nov―26 Impact of the COVID-19 pandemic on psychotropic medication uptake in Northern Ireland: a population-wide trend analysis Lisa Kent, Dermot O'Reilly, Aideen Maguire
333 [GO] 2021―Nov―26 Effects of the COVID-19 pandemic on the mental health of shielded children and children living in shielded households in Wales: a data linkage study Laura Cowley, Jiao Song, Alisha Davies
334 [GO] 2021―Nov―26 Estimating the direct and indirect risks of becoming food insecure during the COVID-19 pandemic: a cross-sectional analysis using UK cohort data Susanna Mills, Viviana Albani, Heather Brown
335 [GO] 2021―Nov―26 Understanding risk and protective factors to UK railway workers' mental wellbeing during the COVID-19 pandemic: a cross-sectional survey Nicola Cogan, Megan McGibbon, Amy Gardener, Liza Morton
336 [GO] 2021―Nov―26 The importance of adaptive coping, peer support, psychological input, team resilience, and supportive management among fire and rescue service workers in maintaining wellbeing throughout the COVID-19 pandemic: a cross-sectional survey Nicola Cogan, Amy MacDonald
337 [GO] 2021―Nov―26 Variations in the incidence of common mental disorder symptoms in the general population throughout the COVID-19 pandemic: a longitudinal cohort study Rob Saunders, Joshua Eusty Jonathan Buckman, Peter Fonagy, Stephen Pilling, Feifei Bu, Daisy Fancourt
338 [GO] 2021―Nov―26 The effect of school and peer connectedness on adolescent mental health outcomes during the COVID-19 pandemic: a longitudinal panel survey Emily Widnall, Lizzy Winstone, Ruth Plackett, Emma Adams, Claire Haworth, Becky Mars, Judi Kidger
339 [GO] 2021―Nov―26 Exploring the role of people providing informal support to survivors of domestic abuse during the COVID-19 pandemic: a qualitative study Alison Gregory, Emma Williamson
340 [GO] 2021―Nov―26 Community-led support in South Wales in response to the COVID-19 pandemic: a qualitative study with a systems-lens approach Lucia Homolova, Charlotte N B Grey, Alisha Davies
341 [GO] 2021―Nov―26 Reduced ability to engage in social and physical activity and mental health of older adults during the COVID-19 pandemic: longitudinal analysis from the Canadian Longitudinal Study on Aging Theodore D Cosco, Andrew Wister, Indira Riadi, Lucy Kervin, John Best, Parminder Raina
342 [GO] 2021―Nov―26 Scientific advice and COVID-19 policy making in the UK: an oral history study Paul Atkinson, Hayley Mableson, Sally Sheard
343 [GO] 2021―Nov―26 COVID-19 recovery from the community perspective in Middlesbrough: a coproduction cross-sectional study Andrew Divers, Catherine Parker, Parisa Diba, Clifford Johnson, Dorothy Newbury-Birch
344 [GO] 2021―Nov―26 Placing health equity at the heart of the COVID-19 recovery: data analysis from the first Welsh Health Equity Status Report initiative James Allen, Andrew Cotter-Roberts, Anna Stielke, Rajendra Kadel, Benjamin Bainham, Kathryn Ashton, et al. (+2)
345 [GO] 2021―Nov―26 Increased COVID-19 related mortality rate for patients with rare diseases: a retrospective cohort study with data from Genomics England Huayu Zhang, Johan Thygesen, Honghan Wu
346 [GO] 2021―Nov―26 Design and implementation of a university-based COVID-19 testing programme: an observational study Claire Blackmore, Gareth W Hall, Rebecca C Allsopp, Anna L Hansell, Caroline M Cowley, Ruth C Barber, et al. (+5)
347 [GO] 2021―Nov―26 Challenges of self-isolation among contacts of cases of COVID-19: a national telephone survey in Wales Kate R Isherwood, Richard G Kyle, Benjamin J Gray, Alisha R Davies
348 [GO] 2021―Nov―26 Community-academic partnerships addressing local health inequalities during COVID-19: a qualitative evaluation Meerat Kaur, Bethany Golding, Arti Maini, Sonia Kumar
349 [GO] 2021―Nov―26 A pilot study of PCR community mass testing for COVID-19: who attends and who tests positive? Kate Levin, Beatrix von Wissmann
350 [GO] 2021―Nov―25 COVID-19 and myocardial infarction Daniel Caldeira, Fausto J Pinto
351 [GO] 2021―Nov―25 COVID-19 and myocardial infarction - Authors' reply Ioannis Katsoularis, Osvaldo Fonseca-Rodríguez, Paddy Farrington, Krister Lindmark, Anne-Marie Fors Connolly
352 [GO] 2021―Nov―25 A reproductive justice response to HIV/AIDS and COVID-19 Jallicia Jolly
353 [GO] 2021―Nov―25 Beyond COVID-19: scaling up and sustaining mobile health in Africa - Authors' reply N Hélène Sawadogo, Hamidou Sanou, Jeremy A Greene, Vincent Duclos
354 [GO] 2021―Nov―25 Beyond COVID-19: scaling up and sustaining mobile health in Africa Yap Boum
355 [GO] 2021―Nov―25 Countries prepare for pandemic treaty decision John Zarocostas
356 [GO] 2021―Nov―18 Long-term effects on survivors with COVID-19 Chengliang Yang, Hedi Zhao, Scott J Tebbutt
357 [GO] 2021―Nov―18 Long-term effects on survivors with COVID-19 Yan-Jie Zhao, Wei Bai, Zhaohui Su, Chee H Ng, Yu-Tao Xiang
358 [GO] 2021―Nov―18 Long-term effects on survivors with COVID-19 - Authors' reply Lixue Huang, Xiaoying Gu, Bin Cao
359 [GO] 2021―Nov―18 Legal challenges threaten Biden's COVID-19 vaccine rule Susan Jaffe
360 [GO] 2021―Nov―18 COVID-19: stigmatising the unvaccinated is not justified Günter Kampf
361 [GO] 2021―Nov―17 Studying the coagulopathy of COVID-19 Alex C Spyropoulos, Marc P Bonaca
362 [GO] 2021―Nov―17 Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, Mustafa Abbas, Sadia Abbasi, Hakam Abbass, et al. (+6209)
363 [GO] 2021―Nov―15 Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA Saad B Omer, Regina M Benjamin, Noel T Brewer, Alison M Buttenheim, Timothy Callaghan, Arthur Caplan, et al. (+16)
364 [GO] 2021―Nov―11 Inactivated SARS-CoV-2 vaccine (BBV152)-induced protection against symptomatic COVID-19 Jing-Xin Li, Feng-Cai Zhu
365 [GO] 2021―Nov―11 Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial Rajeka Lazarus, Sarah Baos, Heike Cappel-Porter, Andrew Carson-Stevens, Madeleine Clout, Lucy Culliford, et al. (+178)
366 [GO] 2021―Nov―11 Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial Raches Ella, Siddarth Reddy, William Blackwelder, Varsha Potdar, Pragya Yadav, Vamshi Sarangi, et al. (+23)
367 [GO] 2021―Nov―11 Just how common is TTS after a second dose of the ChAdOx1 nCov-19 vaccine? Sue Pavord, Marie Scully, Will Lester, Mike Makris, Beverley J Hunt
368 [GO] 2021―Nov―11 Just how common is TTS after a second dose of the ChAdOx1 nCov-19 vaccine? - Authors’ reply Prakash Bhuyan, Jennie Medin, Hugo Gomes da Silva, Madhavi Yadavalli, Magnus Nord
369 [GO] 2021―Nov―10 Global surveillance, research, and collaboration needed to improve understanding and management of long COVID Helen Ward, Barnaby Flower, Patricia J Garcia, Sean Wei Xiang Ong, Daniel M Altmann, Brendan Delaney, et al. (+3)
370 [GO] 2021―Nov―08 How an outbreak became a pandemic: a chronological analysis of crucial junctures and international obligations in the early months of the COVID-19 pandemic Sudhvir Singh, Christine McNab, Rose McKeon Olson, Nellie Bristol, Cody Nolan, Elin Bergstrøm, et al. (+11)
371 [GO] 2021―Nov―04 Health experts welcome Brazil COVID-19 inquiry findings Lise Alves
372 [GO] 2021―Nov―03 Estimating the early impact of the US COVID-19 vaccination programme on COVID-19 cases, emergency department visits, hospital admissions, and deaths among adults aged 65 years and older: an ecological analysis of national surveillance data Lucy A McNamara, Ryan E Wiegand, Rachel M Burke, Andrea J Sharma, Michael Sheppard, Jennifer Adjemian, et al. (+16)
373 [GO] 2021―Nov―03 The value of vaccine programme impact monitoring during the COVID-19 pandemic Justin R Ortiz, Kathleen M Neuzil
374 [GO] 2021―Oct―29 Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study Noam Barda, Noa Dagan, Cyrille Cohen, Miguel A Hernán, Marc Lipsitch, Isaac S Kohane, et al. (+2)
375 [GO] 2021―Oct―28 Characteristics and risk of COVID-19-related death in fully vaccinated people in Scotland Zoe Grange, Audrey Buelo, Christopher Sullivan, Emily Moore, Utkarsh Agrawal, Khaled Boukhari, et al. (+6)
376 [GO] 2021―Oct―28 Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study Raphael Sonabend, Lilith K Whittles, Natsuko Imai, Pablo N Perez-Guzman, Edward S Knock, Thomas Rawson, et al. (+11)
377 [GO] 2021―Oct―28 Unclear conclusions on SARS-CoV-2 elimination versus mitigation Christian Gold
378 [GO] 2021―Oct―28 Unclear conclusions on SARS-CoV-2 elimination versus mitigation - Authors' reply Miquel Oliu-Barton, Bary S R Pradelski, Philippe Aghion, Patrick Artus, Ilona Kickbusch, Jeffrey V Lazarus, Samantha Vanderslott
379 [GO] 2021―Oct―28 Nowcasting towards sustainable SARS-CoV-2 endemicity Gabriel M Leung
380 [GO] 2021―Oct―22 COVID-19 and the rebiologisation of racial difference Wingel Xue, Alexandre White
381 [GO] 2021―Oct―22 Fertility rates and birth outcomes after ChAdOx1 nCoV-19 (AZD1222) vaccination Kushalinii Hillson, Sue Costa Clemens, Shabir A Madhi, Merryn Voysey, Andrew J Pollard, Angela M Minassian
382 [GO] 2021―Oct―15 Developing COVID-19 vaccine policy in increments Michael S Saag
383 [GO] 2021―Oct―09 Depression and anxiety disorders during the COVID-19 pandemic: knowns and unknowns Maxime Taquet, Emily A Holmes, Paul J Harrison
384 [GO] 2021―Oct―09 Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic Damian F Santomauro, Ana M Mantilla Herrera, Jamileh Shadid, Peng Zheng, Charlie Ashbaugh, David M Pigott, et al. (+61)
385 [GO] 2021―Oct―08 Age-adjusted D-dimer cutoffs to guide anticoagulation in COVID-19 - Authors' reply Renato D Lopes, Pedro Gabriel Melo de Barros e Silva, Remo H M Furtado, John H Alexander, Otavio Berwanger
386 [GO] 2021―Oct―08 Age-adjusted D-dimer cutoffs to guide anticoagulation in COVID-19 Marco Zuin, Gianluca Rigatelli, Giovanni Zuliani, Loris Roncon
387 [GO] 2021―Oct―08 The path to global equity in mental health care in the context of COVID-19 Lola Kola, Brandon A Kohrt, Bibhav Acharya, Byamah B Mutamba, Christian Kieling, Manasi Kumar, et al. (+3)
388 [GO] 2021―Oct―07 Can COVID-19 help accelerate and transform the diagnostics agenda? Sabine Kleinert, Richard Horton
389 [GO] 2021―Oct―05 Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study Sara Y Tartof, Jeff M Slezak, Heidi Fischer, Vennis Hong, Bradley K Ackerson, Omesh N Ranasinghe, et al. (+9)
390 [GO] 2021―Oct―05 Navigating from SARS-CoV-2 elimination to endemicity in Australia, Hong Kong, New Zealand, and Singapore Chuan De Foo, Karen A Grépin, Alex R Cook, Li Yang Hsu, Michael Bartos, Sudhvir Singh, et al. (+4)
391 [GO] 2021―Oct―05 Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipients Maria Prendecki, Tina Thomson, Candice L Clarke, Paul Martin, Sarah Gleeson, Rute Cardoso De Aguiar, et al. (+11)
392 [GO] 2021―Sep―30 Extracorporeal membrane oxygenation for COVID-19: evolving outcomes from the international Extracorporeal Life Support Organization Registry Ryan P Barbaro, Graeme MacLaren, Philip S Boonstra, Alain Combes, Cara Agerstrand, Gail Annich, et al. (+10)
393 [GO] 2021―Sep―30 COVID-19 research in LMICs Ivan Sisa, Marco Fornasini, Enrique Teran
394 [GO] 2021―Sep―30 COVID-19 research in LMICs - Authors' reply Irene Torres, Barbara Profeta, Cristiani Vieira Machado, Osvaldo Artaza, Daniel Lopez-Cevallos, JaHyun Kang
395 [GO] 2021―Sep―29 World Heart Day 2021: COVID-19, digital health, and tackling cardiovascular disease Fausto J Pinto, Daniel Piñeiro, Amitava Banerjee, Pablo Perel, Borjana Pervan, Jean-Luc Eiselé
396 [GO] 2021―Sep―29 ECMO in COVID-19: do not blame the tool Alain Vuylsteke
397 [GO] 2021―Sep―24 Functioning of the International Health Regulations during the COVID-19 pandemic Preben Aavitsland, Ximena Aguilera, Seif Salem Al-Abri, Vincent Amani, Carmen C Aramburu, Thouraya A Attia, et al. (+13)
398 [GO] 2021―Sep―23 Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050 Angela E Micah, Ian E Cogswell, Brandon Cunningham, Satoshi Ezoe, Anton C Harle, Emilie R Maddison, et al. (+407)
399 [GO] 2021―Sep―23 COVID-19: learning as an interdependent world The Lancet
400 [GO] 2021―Sep―22 The long-term impact of COVID-19 on development assistance for health is still uncertain Osondu Ogbuoji, Wenhui Mao, Genevieve Aryeetey
401 [GO] 2021―Sep―17 An appeal for an objective, open, and transparent scientific debate about the origin of SARS-CoV-2 Jacques van Helden, Colin D Butler, Guillaume Achaz, Bruno Canard, Didier Casane, Jean-Michel Claverie, et al. (+10)
402 [GO] 2021―Sep―17 An appeal for an objective, open, and transparent scientific debate about the origin of SARS-CoV-2 - Authors' reply Gerald T Keusch, Sai Kit Lam, John S Mackenzie, Linda Saif, Michael Turner
403 [GO] 2021―Sep―17 SARS-CoV-2's origin should be investigated worldwide for pandemic prevention Zhiqiang Wu, Qi Jin, Guizhen Wu, Jian Lu, Mingkun Li, Deyin Guo, et al. (+9)
404 [GO] 2021―Sep―14 Considerations in boosting COVID-19 vaccine immune responses Philip R Krause, Thomas R Fleming, Richard Peto, Ira M Longini, J Peter Figueroa, Jonathan A C Sterne, et al. (+12)
405 [GO] 2021―Sep―14 Daily testing for contacts of individuals with SARS-CoV-2 infection and attendance and SARS-CoV-2 transmission in English secondary schools and colleges: an open-label, cluster-randomised trial Bernadette C Young, David W Eyre, Saroj Kendrick, Chris White, Sylvester Smith, George Beveridge, et al. (+25)
406 [GO] 2021―Sep―10 A new strategy for health and sustainable development in the light of the COVID-19 pandemic Mario Monti, Aleksandra Torbica, Elias Mossialos, Martin McKee
407 [GO] 2021―Sep―02 The long road ahead for COVID-19 vaccination in Africa Sara Jerving
408 [GO] 2021―Sep―02 The race to make a COVID-19 vaccine Sarah Boseley
409 [GO] 2021―Sep―01 Global youth advocating for COVID-19 vaccines for all Neema Kaseje, David Walcott
410 [GO] 2021―Sep―01 Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002) Amy Flaxman, Natalie G Marchevsky, Daniel Jenkin, Jeremy Aboagye, Parvinder K Aley, Brian Angus, et al. (+181)
411 [GO] 2021―Sep―01 Longer intervals and extra doses of ChAdOx1 nCoV-19 vaccine Elizabeth T Rogawski McQuade, Alexander Breskin
412 [GO] 2021―Aug―26 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study Lixue Huang, Qun Yao, Xiaoying Gu, Qiongya Wang, Lili Ren, Yeming Wang, et al. (+19)
413 [GO] 2021―Aug―26 Understanding long COVID: a modern medical challenge The Lancet
414 [GO] 2021―Aug―24 Institutional imperatives for the advancement of women in medicine and science through the COVID-19 pandemic Arghavan Salles, Reshma Jagsi
415 [GO] 2021―Aug―17 SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination Georg MN Behrens, Anne Cossmann, Metodi V Stankov, Inga Nehlmeier, Amy Kempf, Markus Hoffmann, Stefan Pöhlmann
416 [GO] 2021―Aug―13 Tackling Latin America's COVID-19 emergency requires greater solidarity Carissa F Etienne
417 [GO] 2021―Aug―13 Hospital-acquired SARS-CoV-2 infection in the UK's first COVID-19 pandemic wave Jonathan M Read, Chris A Green, Ewen M Harrison, Annemarie B Docherty, Sebastian Funk, Janet Harrison, et al. (+8)
418 [GO] 2021―Aug―13 Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients Edward J Carr, Mary Wu, Ruth Harvey, Emma C Wall, Gavin Kelly, Saira Hussain, et al. (+78)
419 [GO] 2021―Aug―12 SARS-CoV-2 vaccination in pregnancy: a unique opportunity for equity Erkan Kalafat, Laura A Magee, Peter von Dadelszen, Pat O’Brien, Asma Khalil
420 [GO] 2021―Aug―10 The use of inhaled corticosteroids in early-stage COVID-19 Dee Mangin, Michelle Howard
421 [GO] 2021―Aug―10 Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial Ly-Mee Yu, Mona Bafadhel, Jienchi Dorward, Gail Hayward, Benjamin R Saville, Oghenekome Gbinigie, et al. (+46)
422 [GO] 2021―Aug―10 Serial intervals in SARS-CoV-2 B.1.617.2 variant cases Rachael Pung, Tze Minn Mak, Adam J Kucharski, Vernon J Lee
423 [GO] 2021―Aug―09 Towards a European strategy to address the COVID-19 pandemic Viola Priesemann, Rudi Balling, Simon Bauer, Philippe Beutels, André Calero Valdez, Sarah Cuschieri, et al. (+22)
424 [GO] 2021―Aug―06 Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study Richard J Perry, Arina Tamborska, Bhagteshwar Singh, Brian Craven, Richard Marigold, Peter Arthur-Farraj, et al. (+70)
425 [GO] 2021―Aug―06 Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial Xinxue Liu, Robert H Shaw, Arabella S V Stuart, Melanie Greenland, Parvinder K Aley, Nick J Andrews, et al. (+82)
426 [GO] 2021―Aug―06 Optimising SARS-CoV-2 vaccination schedules Cristobal Belda-Iniesta
427 [GO] 2021―Aug―05 COVID-19, online shaming, and health-care professionals Luna Dolezal, Arthur Rose, Fred Cooper
428 [GO] 2021―Aug―05 Critically ill COVID-19 patients in Africa: it is time for quality registry data Luigi Pisani, Wangari Waweru-Siika, Cornelius Sendagire, Abi Beane, Rashan Haniffa
429 [GO] 2021―Aug―05 Critically ill COVID-19 patients in Africa: it is time for quality registry data - Authors' reply Bruce M Biccard, David Thomson, Malcolm Miller, Elliott H Taylor, P Dean Gopalan
430 [GO] 2021―Aug―04 Mucormycosis after COVID-19 in a patient with diabetes Khushboo Chauhan, Deepak Soni, Deepayan Sarkar, Tadepalli Karuna, Bhavana Sharma, Sarman Singh, Samendra Karkhur
431 [GO] 2021―Jul―30 COVID-19 vaccines for children in LMICs: another equity issue Beate Kampmann, Uduak Okomo
432 [GO] 2021―Jul―29 Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study Ioannis Katsoularis, Osvaldo Fonseca-Rodríguez, Paddy Farrington, Krister Lindmark, Anne-Marie Fors Connolly
433 [GO] 2021―Jul―29 What is the association of COVID-19 with heart attacks and strokes? Marion Mafham, Colin Baigent
434 [GO] 2021―Jul―29 Ethnic disparities in COVID-19: increased risk of infection or severe disease? Daniel Pan, Christopher A Martin, Joshua Nazareth, Clareece R Nevill, Jatinder S Minhas, Pip Divall, et al. (+5)
435 [GO] 2021―Jul―29 Ethnic disparities in COVID-19: increased risk of infection or severe disease? - Authors' reply Rohini Mathur, Christopher T Rentsch, Caroline E Morton, Rosalind M Eggo, Krishnan Bhaskaran, Laurie Tomlinsonn, et al. (+2)
436 [GO] 2021―Jul―29 Should global financing be the main priority for pandemic preparedness? Carel IJsselmuiden, Francine Ntoumi, James V Lavery, Jaime Montoya, Salim Abdool Karim, Kirsty Kaiser
437 [GO] 2021―Jul―29 Should global financing be the main priority for pandemic preparedness? - Authors' reply Nicole Lurie, Gerald T Keusch, Victor J Dzau
438 [GO] 2021―Jul―22 Tocilizumab in COVID-19 therapy: who benefits, and how? Avidan U Neumann, Mehmet Goekkaya, Karim Dorgham, Claudia Traidl-Hoffmann, Guy Gorochov
439 [GO] 2021―Jul―22 Tocilizumab in COVID-19 therapy: who benefits, and how? Chengliang Yang, Hedi Zhao
440 [GO] 2021―Jul―22 Tocilizumab in COVID-19 therapy: who benefits, and how? - Authors' reply Peter Horby, Natalie Staplin, Richard Haynes, Martin Landray
441 [GO] 2021―Jul―21 Answering the call to support youth orphaned by COVID-19 Rachel A Kentor, Amanda L Thompson
442 [GO] 2021―Jul―21 Scaling up urban infrastructure for physical activity in the COVID-19 pandemic and beyond Alejandra Jáuregui, Estelle Victoria Lambert, Jenna Panter, Clover Moore, Deborah Salvo
443 [GO] 2021―Jul―21 Global minimum estimates of children affected by COVID-19-associated orphanhood and deaths of caregivers: a modelling study Susan D Hillis, H Juliette T Unwin, Yu Chen, Lucie Cluver, Lorraine Sherr, Philip S Goldman, et al. (+10)
444 [GO] 2021―Jul―20 Will the COVID-19 crisis catalyse universal health reforms? Lucinda Hiam, Robert Yates
445 [GO] 2021―Jul―20 COVID-19: the turning point for gender equality Senait Fisseha, Gita Sen, Tedros Adhanom Ghebreyesus, Winnie Byanyima, Debora Diniz, Henrietta H Fore, et al. (+11)
446 [GO] 2021―Jul―17 In-hospital complications associated with COVID-19 Xiaoying Gu, Bin Cao
447 [GO] 2021―Jul―17 COVID-19 in Africa: a lesson in solidarity The Lancet
448 [GO] 2021―Jul―17 Disruptions to childhood immunisation due to the COVID-19 pandemic Kaja Abbas, Vittal Mogasale
449 [GO] 2021―Jul―17 Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study Kate Causey, Nancy Fullman, Reed J D Sorensen, Natalie C Galles, Peng Zheng, Aleksandr Aravkin, et al. (+12)
450 [GO] 2021―Jul―17 Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study Thomas M Drake, Aya M Riad, Cameron J Fairfield, Conor Egan, Stephen R Knight, Riinu Pius, et al. (+397)
451 [GO] 2021―Jul―17 COVID-19: counting migrants in Sally Hargreaves, Sally E Hayward, Teymur Noori, Martin McKee, Bernadette Kumar
452 [GO] 2021―Jul―08 COVID-19 in Latin America-emergency and opportunity The Lancet
453 [GO] 2021―Jul―08 Addressing the real trajectory of COVID-19 in the Eastern Mediterranean region Khuloud Alsaba
454 [GO] 2021―Jul―08 Addressing the real trajectory of COVID-19 in the Eastern Mediterranean region - Authors' reply Pierre Nabeth, Mahmoud Hassan, Keyrellous Adib, Abdinasir Abubakar, Richard Brennan
455 [GO] 2021―Jul―08 WHO COVID-19 therapeutic guidelines Bram Rochwerg, Thomas Agoritsas, Janet Diaz, Lisa Askie
456 [GO] 2021―Jul―08 WHO COVID-19 therapeutic guidelines - Authors' reply Nicholas J White, Nathalie Strub-Wourgaft, Abul Faiz, Philippe J Guerin
457 [GO] 2021―Jul―08 Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey Mine Durusu Tanriover, Hamdi Levent Doğanay, Murat Akova, Hatice Rahmet Güner, Alpay Azap, Sıla Akhan, et al. (+70)
458 [GO] 2021―Jul―06 7-1-7: an organising principle, target, and accountability metric to make the world safer from pandemics Thomas R Frieden, Christopher T Lee, Aaron F Bochner, Marine Buissonnière, Amanda McClelland
459 [GO] 2021―Jul―05 Science, not speculation, is essential to determine how SARS-CoV-2 reached humans Charles H Calisher, Dennis Carroll, Rita Colwell, Ronald B Corley, Peter Daszak, Christian Drosten, et al. (+18)
460 [GO] 2021―Jul―01 Widespread implementation of a low-cost telehealth service in the delivery of antenatal care during the COVID-19 pandemic: an interrupted time-series analysis Kirsten R Palmer, Michael Tanner, Miranda Davies-Tuck, Andrea Rindt, Kerrie Papacostas, Michelle L Giles, et al. (+9)
461 [GO] 2021―Jul―01 Sparks through the stubble: dying in a pandemic Rachel Clarke
462 [GO] 2021―Jul―01 Learning from crisis: building resilient systems to combat future pandemics Ilona Kickbusch, Gabriel M Leung, Robin J Shattock
463 [GO] 2021―Jun―28 AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC Emma C Wall, Mary Wu, Ruth Harvey, Gavin Kelly, Scott Warchal, Chelsea Sawyer, et al. (+18)
464 [GO] 2021―Jun―25 Heterologous vaccine regimens against COVID-19 Talita Duarte-Salles, Daniel Prieto-Alhambra
465 [GO] 2021―Jun―25 What constitutes success in the roll-out of COVID-19 vaccines? Maxwell J Smith
466 [GO] 2021―Jun―25 Pandemic response requires early and robust verification Susanna Lehtimaki, Pascale Allotey, Nina Schwalbe
467 [GO] 2021―Jun―25 More social discontent than pandemic-related risk perception in Colombia Alvaro J Idrovo
468 [GO] 2021―Jun―24 India's pain: beyond COVID-19 case numbers and mortality rates Rohini Dutta, Tarinee Kucchal
469 [GO] 2021―Jun―24 Can India's COVID-19 emergency be fixed without politics? Kunal Saha
470 [GO] 2021―Jun―24 India's COVID-19 emergency: overarching conclusions belie facts Dhavendra Kumar, Madhukar Mittal
471 [GO] 2021―Jun―24 India's COVID-19 response: science first Nita Radhakrishnan, Devendra Kumar Gupta
472 [GO] 2021―Jun―24 The complex causes of India's 2021 COVID-19 surge Aayush Visaria, Tina Dharamdasani
473 [GO] 2021―Jun―21 Addendum: competing interests and the origins of SARS-CoV-2 Editors of The Lancet
474 [GO] 2021―Jun―18 Five priorities for universal COVID-19 vaccination Adrien Abecassis
475 [GO] 2021―Jun―17 Protecting refugees during the COVID-19 pandemic The Lancet
476 [GO] 2021―Jun―14 SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness Aziz Sheikh, Jim McMenamin, Bob Taylor, Chris Robertson
477 [GO] 2021―Jun―11 SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia treated with immunoglobulin and argatroban Katharina Guetl, Thomas Gary, Reinhard B Raggam, Johannes Schmid, Albert Wölfler, Marianne Brodmann
478 [GO] 2021―Jun―10 Narrative complexity in the time of COVID-19 Aline Gubrium, Erika Gubrium
479 [GO] 2021―Jun―10 From routine data collection to policy design: sex and gender both matter in COVID-19 Mireille Evagora-Campbell, Kakoli Borkotoky, Sneha Sharma, Michelle Mbuthia
480 [GO] 2021―Jun―10 COVID-19 vaccine efficacy data: solid enough to delay second dose? - Authors' reply Sharon Amit, Gili Regev-Yochay, Arnon Afek, Yitshak Kreiss, Eyal Leshem
481 [GO] 2021―Jun―10 COVID-19 vaccine efficacy data: solid enough to delay second dose? John F R Robertson, Herb F Sewell
482 [GO] 2021―Jun―10 Anticoagulation in COVID-19: reaction to the ACTION trial Jeffrey S Berger, Jean Marie Connors
483 [GO] 2021―Jun―10 A strategy for SARS-CoV-2 vaccination in Yemen Abdullah Nasser, Fathiah Zakham
484 [GO] 2021―Jun―10 ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates Elizabeth T Rogawski McQuade, James A Platts-Mills
485 [GO] 2021―Jun―10 ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates - Authors' reply Merryn Voysey, Andrew J Pollard
486 [GO] 2021―Jun―08 Epidemiology, not geopolitics, should guide COVID-19 vaccine donations Thomas J Bollyky, Christopher J L Murray, Robert C Reiner
487 [GO] 2021―Jun―05 Bottom-up citizen engagement for health emergency and disaster risk management: directions since COVID-19 Emily Ying Yang Chan, Nina Gobat, Caroline Dubois, Jamie Bedson, Joao Rangel de Almeida
488 [GO] 2021―Jun―05 Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial Renato D Lopes, Pedro Gabriel Melo de Barros e Silva, Remo H M Furtado, Ariane Vieira Scarlatelli Macedo, Bruna Bronhara, Lucas Petri Damiani, et al. (+42)
489 [GO] 2021―Jun―03 The CEPI centralised laboratory network: supporting COVID-19 vaccine development Arun Kumar, Valentina Bernasconi, Mark Manak, Ana Paula de Almeida Aranha, Paul A Kristiansen
490 [GO] 2021―Jun―03 Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination Emma C Wall, Mary Wu, Ruth Harvey, Gavin Kelly, Scott Warchal, Chelsea Sawyer, et al. (+19)
491 [GO] 2021―Jun―02 Delayed COVID-19 vaccine roll-out in Japan Makoto Kosaka, Takanao Hashimoto, Akihiko Ozaki, Tetsuya Tanimoto, Masahiro Kami
492 [GO] 2021―Jun―01 A pandemic anniversary: 40 years of HIV/AIDS Chris Beyrer
493 [GO] 2021―May―29 Africa's need for more COVID-19 clinical trials Munyaradzi Makoni
494 [GO] 2021―May―29 Cambodia ends controversial COVID-19 restrictions Megan Tatum
495 [GO] 2021―May―28 Mutual aid, pandemic politics, and global social medicine in Brazil Dominique Béhague, Francisco Ortega
496 [GO] 2021―May―25 India's resurgence of COVID-19: urgent actions needed Yamini Aiyar, Vijay Chandru, Mirai Chatterjee, Sapna Desai, Armida Fernandez, Atul Gupta, et al. (+15)
497 [GO] 2021―May―21 Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): a multicentre, prospective, observational cohort study Bruce M Biccard, Pragasan Dean Gopalan, Malcolm Miller, William Lance Michell, David Thomson, Adesoji Ademuyiwa, et al. (+226)
498 [GO] 2021―May―21 What next for a COVID-19 intellectual property waiver? John Zarocostas
499 [GO] 2021―May―21 Excess COVID-19 mortality among critically ill patients in Africa Bruce J Kirenga, Pauline Byakika-Kibwika
500 [GO] 2021―May―21 Gendered effects of COVID-19 on young girls in regions of conflict Sophia N Nesamoney, Gary L Darmstadt, Paul H Wise
501 [GO] 2021―May―21 Refugee access to COVID-19 vaccines in Lebanon Nadine K Jawad, Lina Abu Taweeleh, Jad A Elharake, Nicole Khamis, Osaid Alser, Fatima M Karaki, Layla Aboukhater
502 [GO] 2021―May―14 India's COVID-19 crisis: a call for international action Krutika Kuppalli, Pooja Gala, Kartikeya Cherabuddi, S P Kalantri, Manoj Mohanan, Bhramar Mukherjee, et al. (+7)
503 [GO] 2021―May―14 Convalescent plasma in patients hospitalised with COVID-19 Sean T H Liu, Judith A Aberg
504 [GO] 2021―May―14 Disease surveillance for the COVID-19 era: time for bold changes Oliver W Morgan, Ximena Aguilera, Andrea Ammon, John Amuasi, Ibrahima Socé Fall, Tom Frieden, et al. (+10)
505 [GO] 2021―May―14 Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, Mustafa Abbas, Sadia Abbasi, Hakam Abbass, et al. (+7188)
506 [GO] 2021―May―13 COVID-19 in Turkey: a nation on edge Kaya Genç
507 [GO] 2021―May―13 Long-term effects of COVID-19 on kidney function Philipp Enghard, Jan-Hendrik Hardenberg, Helena Stockmann, Christian Hinze, Kai-Uwe Eckardt, Kai M Schmidt-Ott
508 [GO] 2021―May―13 Long-term effects of COVID-19 on kidney function Pierre Delanaye, Justine Huart, Antoine Bouquegneau, François Jouret
509 [GO] 2021―May―13 Long-term effects of COVID-19 on kidney function - Authors' reply Lixue Huang, Xiaoying Gu, Yeming Wang, Chaolin Huang, Bin Cao
510 [GO] 2021―May―13 Serbia begins paying citizens to receive a COVID-19 vaccine Ed Holt
511 [GO] 2021―May―13 Canada is no global health leader on COVID-19 vaccine equity Adam R Houston, Srinivas Murthy
512 [GO] 2021―May―13 Global COVID-19 vaccine roll-out: time to randomise vaccine allocation? Samuel I Watson, Richard J Lilford
513 [GO] 2021―May―13 Venezuela is collapsing without COVID-19 vaccines Enrique S López Loyo, Marino J González, José Esparza
514 [GO] 2021―May―12 Report of the Independent Panel for Pandemic Preparedness and Response: making COVID-19 the last pandemic Ellen Johnson Sirleaf, Helen Clark
515 [GO] 2021―May―12 Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data Robert H Shaw, Arabella Stuart, Melanie Greenland, Xinxue Liu, Jonathan S Nguyen Van-Tam, Matthew D Snape
516 [GO] 2021―May―07 LSE-Lancet Commission on the future of the NHS: re-laying the foundations for an equitable and efficient health and care service after COVID-19 Michael Anderson, Emma Pitchforth, Miqdad Asaria, Carol Brayne, Barbara Casadei, Anita Charlesworth, et al. (+28)
517 [GO] 2021―May―07 India's COVID-19 emergency The Lancet
518 [GO] 2021―May―07 Priorities for COVID-19 research response and preparedness in low-resource settings Alice Joan Norton, Charles Shey Wiysonge, Jean-Marie Vianney Habarugira, Nicholas John White, Marta Tufet Bayona, Hans-Eckhardt Hagen, et al. (+19)
519 [GO] 2021―May―07 COVID-19 surge threatens health in the Gaza strip Sharmila Devi
520 [GO] 2021―May―06 UK guidelines for managing long-term effects of COVID-19 Waqaar Shah, Melissa Heightman, Stella O'Brien
521 [GO] 2021―May―06 No-fault compensation schemes for COVID-19 medical products Yasuhiro Fujiwara, Yutaka Onda, Shuichiro Hayashi
522 [GO] 2021―May―05 Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data Eric J Haas, Frederick J Angulo, John M McLaughlin, Emilia Anis, Shepherd R Singer, Farid Khan, et al. (+9)
523 [GO] 2021―May―05 COVID-19 vaccine impact in Israel and a way out of the pandemic Eyal Leshem, Annelies Wilder-Smith
524 [GO] 2021―Apr―30 Experts criticise India's complacency over COVID-19 Anoo Bhuyan
525 [GO] 2021―Apr―30 Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, Mustafa Abbas, Sadia Abbasi, Hakam Abbass, et al. (+6343)